Vanderbilt University’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.52M Buy
152,865
+113,395
+287% +$6.16M 0.9% 19
2026
Q1
$2.48M Buy
39,470
+6,836
+21% +$547K 0.47% 27
2025
Q4
$3.11M Buy
32,634
+6,469
+25% +$634K 0.53% 27
2025
Q3
$2.55M Buy
26,165
+12,385
+90% +$1.28M 0.42% 37
2025
Q2
$1.48M Buy
+13,780
New +$1.39M 0.28% 49
2025
Q1
Sell
-23,681
Closed -$2.12M 78
2024
Q4
$2.12M Sell
23,681
-9,214
-28% -$811K 0.41% 42
2024
Q3
$2.76M Sell
32,895
-6,904
-17% -$544K 0.51% 39
2024
Q2
$3.06M Sell
39,799
-3,644
-8% -$267K 0.64% 27
2024
Q1
$2.98M Buy
+43,443
New +$2.79M 0.62% 23

Other funds holding BSX

Vanderbilt University's BSX Position: Q2 2026 in Review

Vanderbilt University increased its Boston Scientific (BSX) stake by 287% in Q2 2026, buying an estimated $6.16M and bringing the position to 152,865 shares worth $6.52M. The position accounts for 0.9% of the portfolio, ranked #19.

Vanderbilt University first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanderbilt University held 152,865 shares of Boston Scientific worth $6.52M as of Q2 2026.
  • Vanderbilt University bought 113,395 Boston Scientific shares in Q2 2026, an estimated $6.16M.
  • Boston Scientific made up 0.9% of Vanderbilt University's portfolio in Q2 2026, its #19 holding.
  • Vanderbilt University first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanderbilt University's 13F filing for Q2 2026, filed 22 Jul 2026.